Programmed Death Ligand-1 (PD-L1) Expression in Patients with Non-Small Cell Lung Cancer (NSCLC) with Unusual Metastasis: A Case Series

被引：0
|
作者：
Tsugitomi, R. [1 ]
Nishimura, N. [1 ]
Imai, R. [1 ]
Okafuji, K. [1 ]
Kitamura, A. [1 ]
Tomishima, Y. [1 ]
Jinta, T. [1 ]
Suzuki, K. [2 ]
Tamura, T. [1 ]
机构：
[1] St Lukes Int Hosp, Dept Pulm Med, Thorac Ctr, Tokyo, Japan
[2] St Lukes Int Hosp, Dept Pathol, Tokyo, Japan
来源：
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE | 2019年 / 199卷
关键词：
D O I：
暂无
中图分类号：
R4 [临床医学];
学科分类号：
1002 ; 100602 ;
摘要：
A3940
引用
收藏
页数：2
相关论文
共 50 条
  • [31] Molecular Epidemiology of Programmed Cell Death 1-Ligand 1 (PD-L1) Protein Expression in Non-Small Cell Lung Cancer
    Schabath, Matthew
    Dalvi, Tapashi
    Dai, Hongyue
    Crim, Alan
    Midha, Anita
    Shire, Norah
    Walker, Jill
    Greenawalt, Danielle
    Lawrence, David
    Rigas, James
    Brody, Robert
    Potter, Danielle
    Kumar, Naveen
    Huntsman, Shane
    Grays, Jhanelle
    JOURNAL OF THORACIC ONCOLOGY, 2017, 12 (01) : S475 - S476
  • [32] Safety and clinical activity of durvalumab (MEDI4736), an anti-programmed cell death ligand-1 (PD-L1) antibody, in patients with non-small cell lung cancer (NSCLC)
    Antonia, Scott
    Rizvi, Naiyer
    Brahmer, Julie
    Ou, Sai-Hong
    Khleif, Samir N.
    Hwu, Wen-Jen
    Gutierrez, Martin
    Schoffski, Patrick
    Hamid, Omid
    Weiss, Jared
    Lutzky, Jose
    Maio, Michele
    Nemunaitis, John
    Jaeger, Dirk
    Balmanoukian, Ani
    Rebelatto, Marlon C.
    Steele, Keith E.
    Jin, Xiaoping
    Robbins, Paul B.
    Blake-Haskins, John A.
    Segal, Neil H.
    CANCER IMMUNOLOGY RESEARCH, 2016, 4 (01)
  • [33] Compare the efficacy and safety of programmed cell death-1 (PD-1) and programmed cell death ligand-1 (PD-L1) inhibitors for advanced non-small cell lung cancer: a Bayesian analysis
    Liang, Jiaqi
    Li, Ming
    Sui, Qihai
    Hu, Zhengyang
    Bian, Yunyi
    Huang, Yiwei
    Zhan, Cheng
    Jiang, Wei
    Wang, Qun
    Tan, Lijie
    TRANSLATIONAL LUNG CANCER RESEARCH, 2020, 9 (04) : 1302 - +
  • [34] PD-L1 expression and genotype in Non-Small Cell Lung Cancer (NSCLC)
    Ansen, S.
    Schultheis, A.
    Hellmich, M.
    Leenders, F.
    Zander, T.
    Michels, S.
    Brockmann, M.
    Stoelben, E.
    Groen, H.
    Timens, W.
    Buettner, R.
    Thomas, R. K.
    Perner, S.
    Wolf, J.
    ONCOLOGY RESEARCH AND TREATMENT, 2014, 37 : 5 - 6
  • [35] PD-L1 expression and genotype in non-small cell lung cancer (NSCLC).
    Ansen, Sascha
    Schultheis, Anne Maria
    Hellmich, Martin
    Zander, Thomas
    Brockmann, Michael
    Stoelben, Erich
    Groen, Harry J. M.
    Timens, Wim
    Buettner, Reinhard
    Thomas, Roman K.
    Perner, Sven
    Wolf, Juergen
    JOURNAL OF CLINICAL ONCOLOGY, 2014, 32 (15)
  • [36] Cost of illness of stage IV non-small cell lung cancer (NSCLC) positive for programmed cell death ligand 1 (PD-L1) in the US
    Kessler, Joshua E.
    Park, Kwon N.
    Grizzle, Amy J.
    Hurwitz, Jason T.
    EXPERT REVIEW OF PHARMACOECONOMICS & OUTCOMES RESEARCH, 2023, 23 (01) : 55 - 61
  • [37] Clinicopathological features of programmed cell death ligand 1 (PD-L1) expression in resected non-small cell lung cancers
    Ohhara, Yoshihito
    Kinoshita, Ichiro
    Tomaru, Utano
    Hatanaka, Kanako C.
    Hatanaka, Yutaka
    Honma, Rio
    Takeuchi, Satoshi
    Shimizu, Yasushi
    Kaga, Kichizo
    Matsuno, Yoshihiro
    Dosaka-Akita, Hirotoshi
    CANCER RESEARCH, 2017, 77
  • [38] Adjuvant Chemotherapy Increases Programmed Death-Ligand 1 (PD-L1) Expression in Non-small Cell Lung Cancer Recurrence
    Lacour, Max
    Hiltbrunner, Stefanie
    Lee, Seok-Yun
    Soltermann, Alex
    Rushing, Elisabeth Jane
    Soldini, Davide
    Weder, Walter
    Curioni-Fontecedro, Alessandra
    CLINICAL LUNG CANCER, 2019, 20 (05) : 391 - 396
  • [39] Correlation Between Programmed Death-1 (PD-1) Expression in Tumor Infiltrating Lymphocytes and Programmed Death Ligand-1 (PD-L1) Expression in Non -Small Cell Lung Carcinoma
    Driver, Brandon
    Miller, Ross A.
    Deavers, Michael
    Tacha, David
    Bernicker, Eric
    Cagle, Philip T.
    MODERN PATHOLOGY, 2017, 30 : 475A - 475A
  • [40] Programmed Death Cell Ligand 1 (PD-L1) Is Associated With Survival in Stage I Non-Small Cell Lung Cancer
    Sepesi, Boris
    Cuentas, Edwin Parra
    Canales, Jaime Rodriguez
    Behrens, Carmen
    Correa, Arlene M.
    Vaporciyan, Ara
    Weissferdt, Annikka
    Kalhor, Neda
    Moran, Cesar
    Swisher, Stephen
    Wistuba, Ignacio
    SEMINARS IN THORACIC AND CARDIOVASCULAR SURGERY, 2017, 29 (03) : 408 - 415
12345